<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PTHI7LTE</identifier><date>2006</date><creator>Drinovec, Jože</creator><creator>Jelić, Julija</creator><creator>Mrhar, Aleš</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-pthi7lte.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-pthi7lte.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-pthi7lte.txt</relation><format format_type="issue">5</format><format format_type="volume">57</format><format format_type="main">9 strani</format><format format_type="type">article</format><format format_type="extent">str. 316-324</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2035057</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PTHI7LTE</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">epidemiologija</subject><subject language_type_id="slv">farmakoepidemiologija</subject><subject language_type_id="slv">sladkorna bolezen</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Družbeno breme sladkorne bolezni tipa 2</title></Record>